Login / Signup

Development and initial clinical correlation of a DNA methylation-based blood test for prostate cancer.

Jacob J K CarsonMichael A Di LenaDavid M BermanD Robert SiemensChristopher R Mueller
Published in: The Prostate (2020)
mDETECT offers a promising tool for the assessment of prostate cancer burden based on the sensitive detection of prostate-specific ctDNA and requires further validation.
Keyphrases
  • prostate cancer
  • sensitive detection
  • radical prostatectomy
  • dna methylation
  • quantum dots
  • gene expression
  • genome wide
  • risk factors
  • copy number